Aggregator
Engineering chimeric antigen receptor CD4 T cells for Alzheimer's disease
Alzheimer's disease (AD) is the prevailing cause of age-associated dementia worldwide. Current standard of care relies on antibody-based immunotherapy. However, antibody-based approaches carry risks for patients, and their effects on cognition are marginal. Increasing evidence suggests that T cells contribute to AD onset and progression. Unlike the cytotoxic effects of CD8^(+) cells, CD4^(+) T cells capable of regulating inflammation show promise in reducing pathology and improving cognitive...
Engineering chimeric antigen receptor CD4 T cells for Alzheimer's disease
Alzheimer's disease (AD) is the prevailing cause of age-associated dementia worldwide. Current standard of care relies on antibody-based immunotherapy. However, antibody-based approaches carry risks for patients, and their effects on cognition are marginal. Increasing evidence suggests that T cells contribute to AD onset and progression. Unlike the cytotoxic effects of CD8^(+) cells, CD4^(+) T cells capable of regulating inflammation show promise in reducing pathology and improving cognitive...
Short-range electrostatic screening in ionic liquids as inferred by direct force measurements
Previous experimental reports of long-range interactions in ionic liquids (ILs) stand in contradiction with theoretical predictions and numerical simulations. To provide insights into the literature discrepancies regarding the experimental ranges of electrostatic screening, claimed with orders of magnitude larger, the interactions between pairs of mica and borosilicate surfaces confining ILs are investigated by two complementary advanced Surface Force Apparatuses. Regardless of differences in...
Aggregation-dependent epitope sequence and modification fingerprints of anti-Aβ antibodies
A hallmark of Alzheimer's disease (AD), the most common form of dementia, is the progressive accumulation of amyloid-beta (Aβ) peptides across distinct brain regions. Anti-Aβ antibodies (Aβ-Abs) targeting specific Aβ variants are essential tools for AD research, diagnostics, and therapy. The monoclonal antibodies Aducanumab, Lecanemab, and Donanemab have recently been approved as the first disease-modifying treatments for early AD, highlighting the clinical importance of their exact binding...
Editorial: Preserving emotional health in aging: unraveling the neural mechanisms and implications for neurodegenerative diseases
No abstract
Kidney function and all-cause mortality in the oldest-old population: a three-cohort longitudinal study
With increasing global life expectancy, the prognostic significance of kidney function in centenarians and supercentenarians should be clarified. The conventional estimated glomerular filtration rate (eGFR) threshold of < 60 mL/min/1.73 m² may not accurately reflect chronic kidney disease (CKD) in this population, highlighting the need for age-adapted definitions. This study investigated the association of kidney function with all-cause mortality across three age groups. Data from the Tokyo...
Leader’s departure marks latest setback for ambitious Japanese science university
Thirteen-year-old Okinawa Institute of Science and Technology hopes to become a global science leader
Coffee linked to slower brain ageing in study of 130,000 people
Daily briefing: The dark side of the battery boom
How to deal with the survey-taking AI agents that threaten to upend social science
The dark side of green technology: what do electric vehicles really cost?
My mission to make life more user friendly for the disability community
Jupiter gets downsized — and squashed
Measles is raging worldwide: are you at risk?
In unprecedented move, giant monkey research center may become a primate sanctuary
University votes to consider ending all studies at Oregon National Primate Research Center. But cost and feasibility are still in doubt
NASA greenlights two earth science missions, to researchers’ relief
Orbiting satellites will monitor changes in the stratosphere and on the planet’s surface
Fire at German particle accelerator could delay multibillion-dollar project
Damage to beam’s power supply marks latest setback for troubled Facility for Antiproton and Ion Research
NAD+ supplementation for anti-aging and wellness: a PRISMA-guided systematic review of preclinical and clinical evidence
Nicotinamide adenine dinucleotide (NAD⁺) declines with age, motivating "NAD⁺-boosting" strategies ranging from lifestyle interventions to supplementation with NAD⁺ precursors (e.g., nicotinamide riboside [NR], nicotinamide mononucleotide [NMN]) and, in some wellness settings, parenteral NAD⁺ administration. We conducted a PRISMA-guided systematic review of peer-reviewed human and rodent intervention studies (January 2010-October 2025) evaluating NAD-related compounds administered orally or...
From ageing clocks to organ networks: Biological age-driven organ asynchrony and inter-organ interactions shaping mortality risk
Ageing is a multidimensional and heterogeneous process that progresses asynchronously across organ systems. Advances in multi-omics technologies have led to the development of diverse ageing clocks, including epigenetic, proteomic, metabolomic, and imaging-based models, which extend beyond estimating crude biological age to more precisely capture organ-specific ageing trajectories and predict age-related diseases and mortality risk. Population-scale studies demonstrate substantial...
Golgi fragmentation driven by the USP11-ITCH axis triggers autolysosomal failure in neurodegeneration
Golgi fragmentation is a prominent early hallmark of neurodegenerative diseases such as Alzheimer disease (AD) and amyotrophic lateral sclerosis (ALS), yet the shared molecular mechanisms underlying this phenomenon remain poorly understood. Here we identify the E3 ubiquitin ligase ITCH as a central regulator of Golgi integrity and proteostasis. Elevated ITCH disrupts both cis- and trans-Golgi networks, dislocates lysosomal hydrolase sorting factors, and impairs maturation of hydrolases. The...